Importantly, PyV MT/jnk2−/− mice also experienced significantly higher numbers of tumors per mouse (i.e. tumor multiplicity), and the heterozygous mice showed an intermediate tumor multiplicity (Figure 1B). Here, MAPK9 is linked to neoplasm.